Shenzhen Neptunus Bioengineering Co., Ltd. (SHE:000078)
China flag China · Delayed Price · Currency is CNY
3.760
+0.160 (4.44%)
Feb 3, 2026, 3:04 PM CST

Shenzhen Neptunus Bioengineering Company Description

Shenzhen Neptunus Bioengineering Co., Ltd. engages in the research and development, production, and sale of Chinese patent medicines, infusion products, and western medicine preparations in China.

The company provides oryzanol tablets, chlorpheniramine maleate tablets, estazolam tablets, and rifampicin capsules, as well as technical support for generic drug quality consistency evaluation and other medical research and development work.

It also distributes drugs, medical devices, and other medical supplies; and offers value-added services for hospitals, medical institutions, and drug retail institutions and distributors.

In addition, the company provides drugs in the fields of malignant tumors, cardiovascular and cerebrovascular diseases, neurodegenerative diseases, diabetes, infectious diseases, and multiple diseases, such as respiratory system and digestive system.

It develops HW130 injection that completed the Phase I clinical trial for anti-tumor; and NEP018 for anti-tumor.

Shenzhen Neptunus Bioengineering Co., Ltd. was founded in 1992 and is headquartered in Shenzhen, China.

Shenzhen Neptunus Bioengineering Co., Ltd.
CountryChina
Founded1992
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees8,264
CEOFeng Zhang

Contact Details

Address:
Neptunus Galaxy Technology Building
Shenzhen, 518057
China
Phone86 755 2696 8666
Websiteneptunusbio.com

Stock Details

Ticker Symbol000078
ExchangeShenzhen Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyCNY
ISIN NumberCNE000000X95
SIC Code5122

Key Executives

NamePosition
Feng ZhangVice Chairman of the Board and President
Da Kai ShenFinancial Director, Vice President and Director
Yi Fei ZhangExecutive Vice President and Director
Rui JinVice President and Non-Independent Director
Yunlei WangVice President, Board Secretary and Director
Xiao Peng WangVice President
Shuangcheng YangVice President
Xiaoming ShiVice President
Ge JinVice President
Shuang Sheng LiAccounting Supervisor